These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 30206167

  • 21. Chlorate Specifically Targets Oxidant-Starved, Antibiotic-Tolerant Populations of Pseudomonas aeruginosa Biofilms.
    Spero MA, Newman DK.
    mBio; 2018 Sep 25; 9(5):. PubMed ID: 30254119
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
    Manos J, Arthur J, Rose B, Bell S, Tingpej P, Hu H, Webb J, Kjelleberg S, Gorrell MD, Bye P, Harbour C.
    FEMS Microbiol Lett; 2009 Mar 25; 292(1):107-14. PubMed ID: 19222585
    [Abstract] [Full Text] [Related]

  • 25. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR, White A, Elborn JS, Tunney MM.
    Eur J Clin Microbiol Infect Dis; 2005 Oct 25; 24(10):677-87. PubMed ID: 16249934
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
    Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA.
    Adv Drug Deliv Rev; 2002 Dec 05; 54(11):1425-43. PubMed ID: 12458153
    [Abstract] [Full Text] [Related]

  • 30. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.
    Schobert M, Jahn D.
    Int J Med Microbiol; 2010 Dec 05; 300(8):549-56. PubMed ID: 20951638
    [Abstract] [Full Text] [Related]

  • 31. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
    Su S, Hassett DJ.
    Expert Opin Ther Targets; 2012 Sep 05; 16(9):859-73. PubMed ID: 22793158
    [Abstract] [Full Text] [Related]

  • 32. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
    Palmer KL, Aye LM, Whiteley M.
    J Bacteriol; 2007 Nov 05; 189(22):8079-87. PubMed ID: 17873029
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ.
    Int J Med Microbiol; 2015 Jan 05; 305(1):1-10. PubMed ID: 25441256
    [Abstract] [Full Text] [Related]

  • 35. Cloning of a Neisseria meningitidis gene for L-lactate dehydrogenase (L-LDH): evidence for a second meningococcal L-LDH with different regulation.
    Erwin AL, Gotschlich EC.
    J Bacteriol; 1996 Aug 05; 178(16):4807-13. PubMed ID: 8759842
    [Abstract] [Full Text] [Related]

  • 36. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.
    Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, Whitchurch CB, Manos J.
    J Med Microbiol; 2010 Sep 05; 59(Pt 9):1089-1100. PubMed ID: 20522626
    [Abstract] [Full Text] [Related]

  • 37. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M.
    J Infect Dis; 2009 Jul 01; 200(1):118-30. PubMed ID: 19459782
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Medium factors on anaerobic production of rhamnolipids by Pseudomonas aeruginosa SG and a simplifying medium for in situ microbial enhanced oil recovery applications.
    Zhao F, Zhou J, Han S, Ma F, Zhang Y, Zhang J.
    World J Microbiol Biotechnol; 2016 Apr 01; 32(4):54. PubMed ID: 26925616
    [Abstract] [Full Text] [Related]

  • 40. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M, Heesemann J.
    Curr Top Microbiol Immunol; 2013 Apr 01; 358():91-118. PubMed ID: 22311171
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.